3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Hepatocellular
42
Parkinson Disease 4, Autosomal Dominant Lewy Body
29
Carcinoma, Renal Cell
26
Endometrial Neoplasms
13
Melanoma
10
Neoplasms
8
Uterine Cervical Neoplasms
7
Cholangiocarcinoma
7
Biliary Tract Neoplasms
7
Liver Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neuroendocrine Tumors
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Thyroid Carcinoma, Anaplastic
3
Recurrence
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
3
Carcinoma, Adenoid Cystic
3
Breast Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma
3
Vulvar Neoplasms
2
Interventions
Fluorouracil
3
lenvatinib
2
Oxaliplatin
2
Leucovorin
2
Drug Therapy
2
gemcitabine-oxaliplatin regimen
1
durvalumab
1
donafenib
1
apatinib
1
Surgical Procedures, Operative
1
Irinotecan
1
Folfox protocol
1
Floxuridine
1
Dexamethasone
1
Cryosurgery
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Cirrhosis, Familial, with Pulmonary Hypertension
×
lenvatinib
×
1 year
×
Clear all
NCT06859684
2026-03-09
HAIC-quad
West China Hospital
Phase 2
Recruiting
25 enrolled
NCT07070700
2025-08-12
CASTLE-ZS-02
Fudan University
Phase 2
Recruiting
56 enrolled